CID 135885159

N-[3-[4-(3,3-dimethylbutyl)-1-hydroxy-3-oxo-4-[[2-(trifluoromethyl)phenyl]methylamino]-2-naphthyl]-1,1-dioxo-4h-1$l^{6},2,4-benzothiadiazin-7-yl]methanesulfonamide

Structural Information

Molecular Formula
C32H33F3N4O6S2
SMILES
CC(C)(C)CCC1(C2=CC=CC=C2C(=C(C1=O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)NS(=O)(=O)C)O)NCC5=CC=CC=C5C(F)(F)F
InChI
InChI=1S/C32H33F3N4O6S2/c1-30(2,3)15-16-31(36-18-19-9-5-7-11-22(19)32(33,34)35)23-12-8-6-10-21(23)27(40)26(28(31)41)29-37-24-14-13-20(38-46(4,42)43)17-25(24)47(44,45)39-29/h5-14,17,36,38,40H,15-16,18H2,1-4H3,(H,37,39)
InChIKey
MBTMOQWJAAIQKA-UHFFFAOYSA-N
Compound name
N-[3-[4-(3,3-dimethylbutyl)-1-hydroxy-3-oxo-4-[[2-(trifluoromethyl)phenyl]methylamino]naphthalen-2-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]methanesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

3
Patents

690.1794 Da
Monoisotopic Mass

4.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 691.18668 252.3
[M+Na]+ 713.16862 257.6
[M-H]- 689.17212 251.5
[M+NH4]+ 708.21322 252.3
[M+K]+ 729.14256 250.7
[M+H-H2O]+ 673.17666 240.8
[M+HCOO]- 735.17760 248.5
[M+CH3COO]- 749.19325 271.2
[M+Na-2H]- 711.15407 261.8
[M]+ 690.17885 253.4
[M]- 690.17995 253.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe